Quorum sensing: une nouvelle cible thérapeutique pour Pseudomonas aeruginosa [Quorum sensing: a new clinical target for Pseudomonas aeruginosa?]

Détails

ID Serval
serval:BIB_EE0269ACE2BF
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Titre
Quorum sensing: une nouvelle cible thérapeutique pour Pseudomonas aeruginosa [Quorum sensing: a new clinical target for Pseudomonas aeruginosa?]
Périodique
Medecine et maladies infectieuses
Auteur⸱e⸱s
Le Berre R., Faure K., Nguyen S., Pierre M., Ader F., Guery B.
ISSN
0399-077X (Print)
ISSN-L
0399-077X
Statut éditorial
Publié
Date de publication
07/2006
Peer-reviewed
Oui
Volume
36
Numéro
7
Pages
349-357
Langue
français
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Résumé
Pseudomonas aeruginosa is an opportunistic bacteria causing a wide variety of infections. The bacterial virulence depends on a large panel of cell-associated and extracellular factors. Quorum sensing (QS) allows cell-to-cell communication: sensing the environment, this system coordinates the expression of various genes within the bacterial population. QS is based on an interaction between a small diffusible molecule, an acylhomoserine lactone (AHL), and a transcriptionnal activator. Two QS systems, the las and rhl systems, have been identified in P. aeruginosa. The las system associates the transcriptionnal activator protein LasR and LasI responsible for the synthesis of a specific AHL: C12-HSL. This system was shown to activate the expression of a large number of virulence factors. Similarly, the rhl system associates the transcriptionnal activator protein RhlR with RhlI, which is responsible for the synthesis of another AHL: C4-HSL. Synthesis and secretion of a number of virulence factors are controlled by QS. Utilization of different animals models showed the crucial role of QS in the pathogenesis of P. aeruginosa infections. The discovery of QS has given a new opportunity to treat bacterial infection by another means than growth inhibition. New drugs inhibiting QS were recently discovered: furanone compounds can repress a large number of QS-regulated genes, including numerous P. aeruginosa virulence factor genes. Furanone administration to mice infected with P. aeruginosa significantly reduced lung bacterial load compared with the control group.
Mots-clé
Cell Communication, Homoserine/analogs & derivatives, Homoserine/metabolism, Homoserine/physiology, Lactones/metabolism, Polymorphism, Genetic, Pseudomonas aeruginosa/genetics, Pseudomonas aeruginosa/pathogenicity
Pubmed
Web of science
Création de la notice
29/04/2021 9:59
Dernière modification de la notice
17/07/2023 14:12
Données d'usage